Literature DB >> 8190855

Implications of directly observed therapy in tuberculosis control measures among IDUs.

R Curtis1, S R Friedman, A Neaigus, B Jose, M Goldstein, D C Des Jarlais.   

Abstract

Tuberculosis (TB) is a rapidly growing problem among injecting drug users (IDU), especially those infected with human immunodeficiency virus. The authors review IDUs' responses to current TB control strategies and discuss the implications of their findings for the proposed implementation of directly observed therapy (DOT), a method for ensuring that patients take prescribed medication. Field workers carried out 210 ethnographic interviews with 68 IDUs in a Brooklyn, NY, community during 1990-93. Case studies suggested that many IDUs are uninformed about TB and often misinformed about their personal TB status. Ethnographic interviews and observations indicated that the threat of TB-related involuntary detainment may lead IDUs to avoid TB diagnostic procedures, treatment for TB, or drug abuse treatment, and to avoid AIDS outreach workers and other health-related services. IDUs who tested positive for the purified protein derivative (PPD) of TB sometimes have left hospitals before definitive diagnoses were made, because of a perceived lack of respectful treatment, fear of detention, or lack of adequate methadone therapy to relieve the symptoms of withdrawal from drugs. Current TB diagnosis and treatment systems are, at best, inadequate. The threat of TB-related detention discourages some IDUs from seeking any type of health care. There is an urgent need to educate IDUs about TB and to educate and sensitize health care providers about the lifestyles of IDUs. DOT may help in servicing this difficult-to-serve population, particularly if techniques are incorporated that have been developed for other successful public health interventions for IDUs.

Entities:  

Mesh:

Year:  1994        PMID: 8190855      PMCID: PMC1403496     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  15 in total

1.  The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis.

Authors:  M E Villarino; L J Geiter; P M Simone
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

2.  Some experts suggest the nation's 'war on drugs' is helping tuberculosis stage a deadly comeback.

Authors:  A A Skolnick
Journal:  JAMA       Date:  1992-12-09       Impact factor: 56.272

3.  Tuberculosis control. Back to the future?

Authors:  F Gordin
Journal:  JAMA       Date:  1992-05-20       Impact factor: 56.272

4.  Leads from the MMWR. Tuberculosis and acquired immunodeficiency syndrome--New York City.

Authors: 
Journal:  JAMA       Date:  1988-01-15       Impact factor: 56.272

5.  High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.

Authors:  P A Selwyn; B M Sckell; P Alcabes; G H Friedland; R S Klein; E E Schoenbaum
Journal:  JAMA       Date:  1992 Jul 22-29       Impact factor: 56.272

6.  The dual epidemics of tuberculosis and AIDS: ethical and policy issues in screening and treatment.

Authors:  R Bayer; N N Dubler; S Landesman
Journal:  Am J Public Health       Date:  1993-05       Impact factor: 9.308

Review 7.  Social and cultural factors in the successful control of tuberculosis.

Authors:  A J Rubel; L C Garro
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

8.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

Authors:  C L Daley; P M Small; G F Schecter; G K Schoolnik; R A McAdam; W R Jacobs; P C Hopewell
Journal:  N Engl J Med       Date:  1992-01-23       Impact factor: 91.245

9.  Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs.

Authors:  K Brudney; J Dobkin
Journal:  Am Rev Respir Dis       Date:  1991-10

Review 10.  Tuberculosis: commentary on a reemergent killer.

Authors:  B R Bloom; C J Murray
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

View more
  16 in total

1.  Does directly observed therapy work?

Authors:  W J Burman; W el-Sadr
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

2.  Directly observed therapy for tuberculosis.

Authors:  S Marks; C Nguyen; N Qualls; Z Taylor
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

3.  Screening and treatment of immigrants and refugees to Canada for tuberculosis: Implications of the experience of Canada and other industrialized countries.

Authors:  R E Thomas; B Gushulak
Journal:  Can J Infect Dis       Date:  1995-09

4.  Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition.

Authors:  M R Kraus; A Schäfer; H Csef; H Faller; H Mörk; M Scheurlen
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

5.  Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.

Authors:  D C Perlman; M N Gourevitch; C Trinh; N Salomon; L Horn; D C Des Jarlais
Journal:  J Urban Health       Date:  2001-09       Impact factor: 3.671

6.  The influence of program acceptability on the effectiveness of public health policy: a study of directly observed therapy for tuberculosis.

Authors:  S J Heymann; R Sell; T F Brewer
Journal:  Am J Public Health       Date:  1998-03       Impact factor: 9.308

Review 7.  Group sex events amongst non-gay drug users: an understudied risk environment.

Authors:  Samuel R Friedman; Pedro Mateu-Gelabert; Milagros Sandoval
Journal:  Int J Drug Policy       Date:  2010-08-25

Review 8.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

9.  Tuberculosis knowledge among New York City injection drug users.

Authors:  H Wolfe; M Marmor; R Maslansky; S Nichols; M Simberkoff; D Des Jarlais; A Moss
Journal:  Am J Public Health       Date:  1995-07       Impact factor: 9.308

10.  Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico.

Authors:  Robert Deiss; Richard S Garfein; Remedios Lozada; Jose Luis Burgos; Kimberly C Brouwer; Kathleen S Moser; Maria Luisa Zuniga; Timothy C Rodwell; Victoria D Ojeda; Steffanie A Strathdee
Journal:  Am J Public Health       Date:  2009-06-18       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.